Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787

BNP7787 (Tavocept, disodium 2,2′-dithio-bis-ethanesulfonate) is a novel, investigational, water-soluble disulfide that is well-tolerated and nontoxic. In separate randomized multicenter Phase II and Phase III clinical trials in non-small-cell lung cancer (NSCLC) patients, treatment with BNP7787 in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Aulma R, Petluru, Pavankumar N, Nienaber, Vicki L, Zhao, Min, Ayala, Philippe Y, Badger, John, Chie-Leon, Barbara, Sridhar, Vandana, Logan, Cheyenne, Kochat, Harry, Hausheer, Frederick H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324543/
https://www.ncbi.nlm.nih.gov/pubmed/25678804
http://dx.doi.org/10.2147/OTT.S73690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324543/
https://www.ncbi.nlm.nih.gov/pubmed/25678804
http://dx.doi.org/10.2147/OTT.S73690

Ejemplares similares